Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey

J Pediatr. 2022 Sep:248:114-118. doi: 10.1016/j.jpeds.2022.05.028. Epub 2022 May 19.

Abstract

The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.

Keywords: COVID-19; MIS-C; SARS-CoV-2; adverse events; vaccination.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / complications
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Child
  • Humans
  • SARS-CoV-2*
  • Surveys and Questionnaires
  • Systemic Inflammatory Response Syndrome
  • Vaccination / adverse effects

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related